Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Alogliptin Monotherapy in Type 2 Diabetes
NCT00286455Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Feb 2006; status: completed.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00286455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286455.